Diabetes & Endocrine Disorders

A Wealth of Experience

We have collaborated with our clients on projects to research diabetes and endocrine disorders, diabetes and endocrine treatments, and complications and comorbidities of diabetes and endocrine disorders. Our experience includes:

  • Type I diabetes
  • Type 2 diabetes
  • Microvascular complications in diabetes including:
    • Diabetic retinopathy
    • Diabetic nephropathy
    • Peripheral neuropathy
  • Macrovascular complications including:
    • Cardiovascular events related to diabetes
    • Peripheral vascular disease
    • Diabetic foot ulcers
  • Obesity

Types of Projects

We have implemented studies to help our clients develop strategies in the diabetes market and to develop and gain market access for products to treat diabetes and endocrine disorders and complications arising from treatment of diabetes. Recent projects have included:

Our Experts

Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Isobel Pearson
Director, Health Economics, Health Technology Assessment
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Sean Candrilli
Head, Health Economics
Patricia Sacco
Senior Director, Surveys and Observational Studies
Andrea Margulis
Director, Epidemiology
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Bintu Sherif
Director, Biostatistics
Lia Gutierrez
Senior Director, Epidemiology
Katherine Houghton
Director, Health Economics
Donald Stull
Head, Data Analytics and Design Strategy
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Juliana Meyers
Director, Health Economics
Michele Wilson
Director, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Will Herring
Director, Health Economics
Carol Mansfield
Senior Research Economist
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Caroline Ling
Senior Director, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Annete Njue
Director, Market Access and Outcomes Strategy
Costel Chirila
Director, Biostatistics
Keith Davis
Senior Director, Health Economics
Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Doreen McBride
Head, HTA Health Economics Strategy and Research
Emma Hawe
Senior Director, Data Analytics and Design Strategy
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Manel Pladevall-Vila
Senior Director, Epidemiology
Catherine Masaquel
Senior Director, Market Access and Outcomes Strategy
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Katherine Hicks
Director, Health Economics
Mary Anthony
Director, Epidemiology
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Colleen Castro
Senior Associate, Market Access and Outcomes Strategy
Lauren Nelson
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
Alicia Gilsenan
Senior Director, Epidemiology
Christine Poulos
Senior Research Economist